Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Endra Life Sciences Inc (NQ: NDRA )

4.850 -0.440 (-8.32%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Endra Life Sciences Inc

< Previous 1 2 3 Next >
ENDRA Life Sciences to Report First Quarter 2022 Financial Results on May 12, 2022
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Raises $8.7 Million in Gross Proceeds Through its At-The-Market Facility
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Achieves Key Quality Management System Certification
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Strengthens TAEUS® System Global Intellectual Property Protection with Issuance of 10th and 11th Chinese Patents
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences to Report Fourth Quarter 2021 Financial Results on March 30, 2022
From ENDRA Life Sciences Inc.
Via Business Wire
The Stock Day Podcast Hosted ENDRA Life Sciences Inc. to Discuss the Potential of its Thermo Acoustic Enhanced UltraSound (TAEUS(R))
Phoenix, Arizona--(Newsfile Corp. - February 15, 2022) - The Stock Day Podcast welcomed ENDRA Life Sciences Inc. (NASDAQ: NDRA) ("the... 
Via Newsfile
ENDRA Life Sciences Strengthens TAEUS® System Global Intellectual Property Portfolio with Issuance of 6th and 7th European Patents
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Provides Update on U.S. Regulatory Strategy for its TAEUS® System
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Expands into China with Shanghai General Hospital Partnership
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences to Present at the H.C. Wainwright BioConnect Virtual Conference
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Announces New Clinical Study Partnership with King’s College Hospital, London
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Expands Pharmaceutical Partnerships with VGI Health Technology to Provide TAEUS for Patient Screening and Biomarker Measurement for Phase 2 Study
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Further Strengthens TAEUS® System Intellectual Property with Issuance of 22nd and 23rd U.S. Patents
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Reports Third Quarter 2021 Financial Results and Provides Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences to Report Third Quarter 2021 Financial Results on November 15, 2021
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Further Strengthens TAEUS® System Intellectual Property Protection with Issuance of 21st U.S. Patent
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences to Participate in the H.C. Wainwright 5th Annual NASH Investor Conference
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences to Participate in Two Upcoming Investment Conferences
ANN ARBOR, MI / ACCESSWIRE / September 7, 2021 / ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that management will participate in two... 
From ENDRA Life Sciences Inc.
Via AccessWire
ENDRA Life Sciences Reports Second Quarter 2021 Financial Results and Provides Business Update
Conference call begins at 4:30 p.m. Eastern time today ANN ARBOR, MI / ACCESSWIRE / August 12, 2021 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound... 
From ENDRA Life Sciences Inc.
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
ENDRA Life Sciences to Report Second Quarter 2021 Financial Results on August 12, 2021
ANN ARBOR, MI / ACCESSWIRE / August 2, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of enhanced ultrasound technologies, today announced that the company will report financial... 
From ENDRA Life Sciences Inc.
Via AccessWire
ENDRA Life Sciences Announces Participation in A.G.P.'s Virtual MedTech Summer Conference on July 29, 2021
ANN ARBOR, MI / ACCESSWIRE / July 20, 2021 / ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that management will participate in A.G.P.'s... 
From ENDRA Life Sciences Inc.
Via AccessWire
ENDRA Life Sciences Strengthens TAEUS(R) System Intellectual Property Protection with the Issuance of Three U.S. Patents
ANN ARBOR, MI / ACCESSWIRE / July 7, 2021 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces the strengthening of its global patent... 
From ENDRA Life Sciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
ENDRA Life Sciences Appoints Irina Pestrikova as Senior Director of Finance, Announces Departure of CFO David Wells
ANN ARBOR, MI / ACCESSWIRE / June 15, 2021 / ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announced the appointment of Irina Pestrikova as Senior... 
From ENDRA Life Sciences Inc.
Via AccessWire
Topics Initial Public Offering Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
ENDRA Life Sciences Set to Join the Russell Microcap(R) Index
ANN ARBOR, MI / ACCESSWIRE / June 9, 2021 / ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that it is expected to be added to the Russell... 
From ENDRA Life Sciences Inc.
Via AccessWire
Topics Derivatives Intellectual Property
Exposures COVID-19 Derivatives Intellectual Property
ENDRA Life Sciences Reports First Quarter 2021 Financial Results and Provides Business Update
Conference call begins at 4:30 p.m. Eastern time today ANN ARBOR, MI / ACCESSWIRE / May 17, 2021 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound... 
From ENDRA Life Sciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures COVID-19 Intellectual Property Product Safety
ENDRA Life Sciences to Report First Quarter 2021 Financial Results on May 17, 2021
ANN ARBOR, MI / ACCESSWIRE / May 6, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of enhanced ultrasound technologies, today announced that the company will report financial results... 
From ENDRA Life Sciences Inc.
Via AccessWire
ENDRA Life Sciences Further Strengthens TAEUS(R) System's Intellectual Property Protection with Issuance of Two U.S. Patents
ANN ARBOR, MI / ACCESSWIRE / May 4, 2021 / ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces the Company has recently been issued U.S. Patent... 
From ENDRA Life Sciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Clinical Trials Critical for the Evaluation of Advanced Medical Imaging Tools
Via FinancialNewsMedia
ENDRA Life Sciences to Present at AIUM Annual Integrative Ultrasound Meeting
ANN ARBOR, MI / ACCESSWIRE / April 8, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that the Company's Chief... 
From ENDRA Life Sciences Inc.
Via AccessWire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.